egualen 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
993 99287-30-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • azuloxa
  • egualen sodium hydrate
  • egualen sodium
  • KT1–32
  • egualen
  • azuletil
a stable azulene derivative, antiulcer agent
  • Molecular weight: 278.37
  • Formula: C15H18O3S
  • CLOGP: 2.98
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 1
  • TPSA: 54.37
  • ALOGS: -4.03
  • ROTB: 3

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None PMDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:49201 anti-ulcer drugs
CHEBI has role CHEBI:85540 thromboxane A2 antagonists

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Gastric ulcer indication 397825006 DOID:10808




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.4 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
97683-31-3 SECONDARY_CAS_RN
C2348385 UMLSCUI
CHEBI:85542 CHEBI
CHEMBL2105570 ChEMBL_ID
C061956 MESH_SUPPLEMENTAL_RECORD_UI
65858 PUBCHEM_CID
6823 INN_ID
17VM9WN49U UNII

Pharmaceutical products:

None